...
首页> 外文期刊>Molecules and cells >Proangiogenic TIE2+/CD31+ Macrophages Are the Predominant Population of Tumor-Associated Macrophages Infiltrating Metastatic Lymph Nodes
【24h】

Proangiogenic TIE2+/CD31+ Macrophages Are the Predominant Population of Tumor-Associated Macrophages Infiltrating Metastatic Lymph Nodes

机译:促血管生成的TIE2 + / CD31 +巨噬细胞是浸润转移淋巴结的肿瘤相关巨噬细胞的主要种群。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Tumor-associated macrophages (TAMs) accumulate in various cancers and promote tumor angiogenesis and metastasis, and thus may be ideal targets for the clinical diagnosis of tumor metastasis with high specificity. However, there are few specific markers to distinguish between TAMs and normal or inflammatory macrophages. Here, we show that TAMs localize in green fluorescent protein-labeled tumors of metastatic lymph nodes (MLNs) from B16F1 melanoma cells but not in necrotic tumor regions, suggesting that TAMs may promote the growth of tumor cells and the progression of tumor metastasis. Furthermore, we isolated pure populations of TAMs from MLNs and characterized their gene expression signatures compared to peritoneal macrophages (PMs), and found that TAMs significantly overexpress immunosuppressive cytokines such as IL-4, IL-10, and TGF ? as well as proangiogenic factors such as VEGF, TIE2, and CD31. Notably, immunological analysis revealed that TIE2+/CD31+ macrophages constitute the predominant population of TAMs that infiltrate MLNs, distinct from tissue or inflammatory macrophages. Importantly, these TIE2+/CD31+ macropha-ges also heavily infiltrated MLNs from human breast can-cer biopsies but not reactive hyperplastic LNs. Thus, TIE2+/ CD31+ macrophages may be a unique histopathological biomarker for detecting metastasis in clinical diagnosis, and a novel and promising target for TAM-specific cancer therapy.
机译:肿瘤相关巨噬细胞(TAM)在各种癌症中积累并促进肿瘤血管生成和转移,因此可能是高度特异性地临床诊断肿瘤转移的理想靶标。但是,几乎没有特异性标志物可区分TAM和正常或炎性巨噬细胞。在这里,我们显示TAM位于B16F1黑色素瘤细胞的绿色荧光蛋白标记的转移性淋巴结(MLN)肿瘤中,而不位于坏死性肿瘤区域,这表明TAM可能促进肿瘤细胞的生长和肿瘤转移的进程。此外,我们从MLNs中分离出了纯TAMs群体,并与腹膜巨噬细胞(PMs)相比,表征了它们的基因表达特征,发现TAMs明显过表达免疫抑制细胞因子,例如IL-4,IL-10和TGFβ。以及促血管生成因子,例如VEGF,TIE2和CD31。值得注意的是,免疫学分析显示TIE2 + / CD31 +巨噬细胞是渗透MLN的TAM的主要种群,与组织或炎性巨噬细胞不同。重要的是,这些TIE2 + / CD31 +巨噬细胞还从人乳腺癌的活检组织中浸润了MLN,但没有反应性增生性LN浸润。因此,TIE2 + / CD31 +巨噬细胞可能是用于在临床诊断中检测转移的独特组织病理学生物标志物,并且是TAM特异性癌症治疗的新的有希望的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号